Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/01/19 | Annual report pursuant to Section 13 and 15(d) |
|
16 | ||
| 03/29/19 | Annual report pursuant to Section 13 and 15(d) |
|
 |
134 | |
| 03/28/19 | Current report filing |
|
7 | ||
| 02/06/19 | Current report filing |
|
5 | ||
| 01/22/19 | Current report filing |
|
6 | ||
| 01/02/19 | Current report filing |
|
3 | ||
| 12/26/18 | Current report filing |
|
3 | ||
| 11/14/18 | Quarterly report pursuant to Section 13 or 15(d) |
|
|
52 | |
| 11/13/18 | Current report filing |
|
9 | ||
| 11/02/18 | Current report filing |
|
3 |